Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR)

被引:98
作者
Chao, Elizabeth C. [1 ]
Velasquez, Jonathan L. [1 ]
Witherspoon, Mavee S. L. [1 ]
Rozek, Laura S. [2 ]
Peel, David [1 ]
Ng, Pauline [3 ]
Gruber, Stephen B. [2 ]
Watson, Patrice [4 ]
Rennert, Gad [5 ,6 ,7 ]
Anton-Culver, Hoda [1 ]
Lynch, Henry [4 ]
Lipkin, Steven M. [1 ]
机构
[1] Univ Calif Irvine, Canc Genet Clin, Div Hematol Oncol, Genet Epidemiol Res Inst, Irvine, CA 92697 USA
[2] Univ Michigan, Dept Internal Med Epidemiol & Human Genet, Ann Arbor, MI 48109 USA
[3] J Craig Venter Inst Human Genet, Rockville, MD USA
[4] Creighton Univ, Sch Med, Hereditary Canc Inst, Omaha, NE USA
[5] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel
[6] Techn Faculty Med, Haifa, Israel
[7] CHS Natl Canc Control Ctr, Haifa, Israel
关键词
Lynch syndrome; colorectal cancer; variants of uncertain significance; cancer genetics; HNPCC; MLH1; MSH;
D O I
10.1002/humu.20735
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome, also known as hereditary nonpolyposis colon cancer (HNPCC), is the most common known genetic syndrome for colorectal cancer (CRC). MLH1/MSH2 mutations underlie approximately 90% of Lynch syndrome families. A total of 24% of these mutations are missense. Interpreting missense variation is extremely challenging. We have therefore developed multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR), a bioinformatic algorithm that effectively classifies MLH1/MSH2 deleterious and neutral missense variants. We compiled a large database (n>300) of MLH1/MSH2 missense variants with associated clinical and molecular characteristics. We divided this database into nonoverlapping training and validation sets and tested MAPP-MMR. MAPP-MMR significantly outperformed other missense variant classification algorithms (sensitivity, 94%; specificity, 96%; positive predictive value [PPV] 98%; negative predictive value [NPV], 89%), such as SIFT and PolyPhen. MAPP-MMR is an effective bioinformatic tool for missense variant interpretation that accurately distinguishes MLH1/MSH2 deleterious variants from neutral variants.
引用
收藏
页码:852 / 860
页数:9
相关论文
共 58 条
  • [31] Predicting deleterious amino acid substitutions
    Ng, PC
    Henikoff, S
    [J]. GENOME RESEARCH, 2001, 11 (05) : 863 - 874
  • [32] Accounting for human polymorphisms predicted to affect protein function
    Ng, PC
    Henikoff, S
    [J]. GENOME RESEARCH, 2002, 12 (03) : 436 - 446
  • [33] Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer:: International Society for Gastrointestinal Hereditary Tumours Collaborative Study
    Park, Jae-Gahb
    Kim, Duck-Woo
    Hong, Chang Won
    Nam, Byung-Ho
    Shin, Young-Kyoung
    Hong, Sung-Hye
    Kim, Il-Jin
    Lim, Seok-Byung
    Aronson, Melyssa
    Bisgaard, Marie Luise
    Brown, Gregor J.
    Burn, John
    Chow, Elizabeth
    Conrad, Peggy
    Douglas, Fiona
    Dunlop, Malcolm
    Ford, James
    Greenblatt, Marc S.
    Heikki, Jarvinen
    Heinimann, Karl
    Lynch, Elly L.
    Macrae, Finlay
    McKinnon, Wendy C.
    Moeeslein, Gabriela
    Rossi, Benedito Mauro
    Rozen, Paul
    Schofield, Lyn
    Vaccaro, Carlos
    Vasen, Hans
    Velthuizen, Mary
    Viel, Alessandra
    Wijnen, Juul
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (11) : 3389 - 3393
  • [34] Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases
    Peel, DJ
    Ziogas, A
    Fox, EA
    Gildea, M
    Laham, B
    Clements, E
    Kolodner, RD
    Anton-Culver, H
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) : 1517 - 1522
  • [35] Mutations associated with HNPCC predisposition -: Update of ICG-HNPCC/INSiGHT mutation database
    Peltomäki, P
    Vasen, H
    [J]. DISEASE MARKERS, 2004, 20 (4-5) : 269 - 276
  • [36] Classification of BRCA1 missense variants of unknown clinical significance
    Phelan, CM
    Dapic, V
    Tice, B
    Favis, R
    Kwan, E
    Barany, F
    Manoukian, S
    Radice, P
    van der Luijt, RB
    van Nesselrooij, BPM
    Chenevix-Trench, G
    Caldes, T
    de La Hoya, M
    Lindquist, S
    Tavtigian, SV
    Goldgar, D
    Borg, Å
    Narod, SA
    Monteiro, ANA
    [J]. JOURNAL OF MEDICAL GENETICS, 2005, 42 (02) : 138 - 146
  • [37] Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer
    Piñol, V
    Castells, A
    Andreu, M
    Castellví-Bel, S
    Alenda, C
    Llor, X
    Xicola, RM
    Rodríguez-Moranta, F
    Payá, A
    Jover, R
    Bessa, X
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (16): : 1986 - 1994
  • [38] Statins and the risk of colorectal cancer
    Poynter, JN
    Gruber, SB
    Higgins, PDR
    Almog, R
    Bonner, JD
    Rennert, HS
    Low, M
    Greenson, JK
    Rennert, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (21) : 2184 - 2192
  • [39] Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1
    Raevaara, TE
    Korhonen, MK
    Lohi, H
    Hampel, H
    Lynch, E
    Lönnqvist, KE
    Holinski-Feder, E
    Sutter, C
    McKinnon, W
    Duraisamy, S
    Gerdes, AM
    Peltomäki, P
    Kohonen-Corish, M
    Mangold, E
    Macrae, F
    Greenblatt, M
    de la Chapelle, A
    Nyström, M
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 537 - 549
  • [40] Human non-synonymous SNPs: server and survey
    Ramensky, V
    Bork, P
    Sunyaev, S
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (17) : 3894 - 3900